About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P

by Medindia Content Team on July 26, 2006 at 4:57 AM
Font : A-A+

Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P

Pharma company Lupin Ltd today said it has received approval from the Drugs Controller General (India) (DCGI) to conduct Phase II clinical trials for the molecule LL-42 18 (Desoside-P).

The company received permission to continue Phase II clinical trials on the Psoriasis pure compound, LL-42 18, after DCGI found the clinical Phase I data of the molecule to be satisfactory.

Advertisement

Lupin informed the Bombay Stock Exchange that it intends to begin clinical trials at 5-6 centres immediately.

'We are delighted that our Phase I data has been found to be satisfactory for us to proceed with further clinical trials. We are very excited with taking the molecule forward and look forward to meeting this otherwise unmet market need,' Company Chairman Desh Bandhu Gupta said.
Advertisement

LL-4218, a pure molecule, is obtained from a plant source and is intended for the treatment of chronic stable plaque type psoriasis. This molecule's novel mechanism of action leads to marked psoriatic lesion improvement without any toxic effects.

The company said it also has three other new chemical entities in various stages of clinical trials.

Source:PTI News
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
H1N1 Influenza Prevention in Children: What Parents Need to Know
Dietary Factors Responsible for Dihydrotestosterone (DHT) Production and Hair Loss
Test Your Knowledge About Chromosomes?
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Clinical Trials Clinical Trials - The Past and The Future Clinical Trials - Different Phases of the trial Placebo Effects: Rare Insights 

Most Popular on Medindia

Noscaphene (Noscapine) How to Reduce School Bag Weight - Simple Tips Accident and Trauma Care The Essence of Yoga A-Z Drug Brands in India Blood Donation - Recipients Nutam (400mg) (Piracetam) Drug Side Effects Calculator Color Blindness Calculator Indian Medical Journals
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Lupin Gets DCGI Nod For Phase II Clinical Trials On Desoside-P Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests